Eprontia
Topiramate
- Strength
- 25 mg/mL
- Form
- Solution
Azurity Pharmaceuticals, Inc.
Listed by Zydus Lifesciences Limited
| Dosage form | Capsule, Coated Pellets |
|---|---|
| Route | Oral |
| Approval route | ANDA — approved generic |
| NDC code | 65841-651 |
| FDA application | ANDA078877 |
| RxNorm concept | 205315 |
| Package sizes listed | 5 |
| Marketed since | October 2009 |
Same active ingredient, different manufacturer, strength or form. Products matching on both ingredient and strength are usually interchangeable — but confirm before switching, especially with modified-release forms.
Topiramate
Azurity Pharmaceuticals, Inc.
Topiramate
Upsher-Smith Laboratories, LLC
Topiramate
Upsher-Smith Laboratories, LLC
Topiramate
Upsher-Smith Laboratories, LLC
Topiramate
Upsher-Smith Laboratories, LLC
Topiramate
Upsher-Smith Laboratories, LLC
topiramate
Janssen Pharmaceuticals, Inc.
topiramate
Janssen Pharmaceuticals, Inc.
Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.
Please don't share card details in chat.